Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger A Barker

Showing results (81-90 of 452) with videos related to

Pageof 46
Sort By:
Clinical Chemistry and Laboratory Medicine|February 4, 2011
Parkinson's disease--the continuing search for biomarkersDavid P Breen, Andrew W Michell, Roger A Barker
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Animal models of neurodegenerative diseasesWendy Phillips, Andrew Michell, Harald Pruess, et al.
Journal of Neuropsychology|January 3, 2013
Revisiting the effects of Parkinson's disease and frontal lobe lesions on task switching: the role of rule reconfigurationAngie A Kehagia, Roger A Barker, Trevor W Robbins
Journal of Huntington'S Disease|May 30, 2023
Sleep Dysfunction in Huntington's Disease: Impacts of Current Medications and Prospects for TreatmentNatalia E Owen, Roger A Barker, Zanna J Voysey
Neuro-Degenerative Diseases|October 6, 2012
Cognitive impairment in Parkinson's disease: the dual syndrome hypothesisAngie A Kehagia, Roger A Barker, Trevor W Robbins
Journal of Parkinson'S Disease|April 5, 2021
Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson's Disease to the Clinic: The Investigator's PerspectiveRoger A Barker, Emma V Cutting, Danielle M Daft
Expert Opinion on Investigational Drugs|May 17, 2024
Inflammation and Huntington's disease - a neglected therapeutic target?Sophie E Field, Annabel J Curle, Roger A Barker
Cell Stem Cell|November 4, 2017
Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New EraRoger A Barker, Malin Parmar, Lorenz Studer, et al.
Experimental Neurology|January 10, 2013
Stem cells and the treatment of Parkinson's diseaseFahad Ali, Simon R W Stott, Roger A Barker
NPJ Parkinson'S Disease|July 21, 2017
G-Force PD: a global initiative in coordinating stem cell-based dopamine treatments for Parkinson's diseaseRoger A Barker, Lorenz Studer, Elena Cattaneo, et al.
Pageof 46

Showing results (81-90 of 452) with videos related to

Sort By:
Pageof 46
Clinical Chemistry and Laboratory Medicine|February 4, 2011
Parkinson's disease--the continuing search for biomarkersDavid P Breen, Andrew W Michell, Roger A Barker
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Animal models of neurodegenerative diseasesWendy Phillips, Andrew Michell, Harald Pruess, et al.
Journal of Neuropsychology|January 3, 2013
Revisiting the effects of Parkinson's disease and frontal lobe lesions on task switching: the role of rule reconfigurationAngie A Kehagia, Roger A Barker, Trevor W Robbins
Journal of Huntington'S Disease|May 30, 2023
Sleep Dysfunction in Huntington's Disease: Impacts of Current Medications and Prospects for TreatmentNatalia E Owen, Roger A Barker, Zanna J Voysey
Neuro-Degenerative Diseases|October 6, 2012
Cognitive impairment in Parkinson's disease: the dual syndrome hypothesisAngie A Kehagia, Roger A Barker, Trevor W Robbins
Journal of Parkinson'S Disease|April 5, 2021
Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson's Disease to the Clinic: The Investigator's PerspectiveRoger A Barker, Emma V Cutting, Danielle M Daft
Expert Opinion on Investigational Drugs|May 17, 2024
Inflammation and Huntington's disease - a neglected therapeutic target?Sophie E Field, Annabel J Curle, Roger A Barker
Cell Stem Cell|November 4, 2017
Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New EraRoger A Barker, Malin Parmar, Lorenz Studer, et al.
Experimental Neurology|January 10, 2013
Stem cells and the treatment of Parkinson's diseaseFahad Ali, Simon R W Stott, Roger A Barker
NPJ Parkinson'S Disease|July 21, 2017
G-Force PD: a global initiative in coordinating stem cell-based dopamine treatments for Parkinson's diseaseRoger A Barker, Lorenz Studer, Elena Cattaneo, et al.
Pageof 46